These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 26899578)
1. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis. Küng E; Pietrzak J; Klaus C; Walochnik J Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578 [TBL] [Abstract][Full Text] [Related]
2. Pentamycin shows high efficacy against Trichomonas vaginalis. Kranzler M; Syrowatka M; Leitsch D; Winnips C; Walochnik J Int J Antimicrob Agents; 2015 Apr; 45(4):434-7. PubMed ID: 25703311 [TBL] [Abstract][Full Text] [Related]
3. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623 [TBL] [Abstract][Full Text] [Related]
4. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States. Butler SE; Augostini P; Secor WE Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315 [TBL] [Abstract][Full Text] [Related]
5. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis]. Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960 [TBL] [Abstract][Full Text] [Related]
6. The Role of Iron Status in the Early Progression of Metronidazole Resistance in Trichomonas vaginalis Under Microaerophilic Conditions. Argáez-Correa W; Alvarez-Sánchez ME; Arana-Argáez VE; Ramírez-Camacho MA; Novelo-Castilla JS; Coral-Martínez TI; Torres-Romero JC J Eukaryot Microbiol; 2019 Mar; 66(2):309-315. PubMed ID: 30047563 [TBL] [Abstract][Full Text] [Related]
7. Chlorinated metronidazole as a promising alternative for treating trichomoniasis. Chacon MO; Fonseca THS; Oliveira SBV; Alacoque MA; Franco LL; Tagliati CA; Cassali GD; Campos-Mota GP; Alves RJ; Capettini LSA; Gomes MA Parasitol Res; 2018 May; 117(5):1333-1340. PubMed ID: 29502297 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis. Blaha C; Duchêne M; Aspöck H; Walochnik J J Antimicrob Chemother; 2006 Feb; 57(2):273-8. PubMed ID: 16344287 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the in vitro activity of ceragenins against Trichomonas vaginalis. Polat ZA; Cetin A; Savage PB Acta Parasitol; 2016 Mar; 61(2):376-81. PubMed ID: 27078662 [TBL] [Abstract][Full Text] [Related]
10. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea. Upcroft JA; Dunn LA; Wal T; Tabrizi S; Delgadillo-Correa MG; Johnson PJ; Garland S; Siba P; Upcroft P Sex Health; 2009 Dec; 6(4):334-8. PubMed ID: 19917203 [TBL] [Abstract][Full Text] [Related]
11. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity. Malla N; Kaul P; Sehgal R; Gupta I Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110 [TBL] [Abstract][Full Text] [Related]
12. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates. Goodhew EB; Secor WE Sex Transm Infect; 2013 Sep; 89(6):479-84. PubMed ID: 23794105 [TBL] [Abstract][Full Text] [Related]
13. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis. Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243 [TBL] [Abstract][Full Text] [Related]
14. Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not. Wright JM; Webb RI; O'Donoghue P; Upcroft P; Upcroft JA J Eukaryot Microbiol; 2010; 57(2):171-6. PubMed ID: 20015182 [TBL] [Abstract][Full Text] [Related]
15. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole]. Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of some medicinal plants on cultured Trichomonas Vaginalis. Selim MA; Fawzy EM; Abd El-Rahman EM; Abdel Hady RS; Badr MS; Abdel Hamed EF J Infect Dev Ctries; 2020 Jul; 14(7):793-799. PubMed ID: 32794472 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of netropsin dihydrochloride against the viability, cytopathogenicity and hemolytic activity of Trichomonas vaginalis clinical isolates. Abou Gamra MM; Kamel HH; Ezz Eldin HM; Taha Zahran FM J Infect Chemother; 2019 Dec; 25(12):955-964. PubMed ID: 31189504 [TBL] [Abstract][Full Text] [Related]